| |
| |
|
| Insider
Information: |
Scangos George A |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
937,662 |
|
|
Indirect Shares
|
3,762,360 |
|
|
| Direct
Value |
$29,778,144 |
|
|
|
Indirect Value
|
$4,974,217 |
|
|
| Total
Shares |
4,700,022 |
|
|
| Total
Value |
$34,752,361 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Exelixis Inc |
EXEL |
Director |
2020-05-18 |
714,717 |
2020-05-18 |
23,595 |
Premium* |
|
|
Anadys Pharmaceuticals Inc |
ANDS |
Director |
2008-08-26 |
33,188 |
2004-03-31 |
0 |
Premium* |
|
|
Biogen Idec Inc |
BIIB |
Chief Executive Office... |
2016-07-21 |
54,779 |
2016-07-21 |
10,756 |
Premium* |
|
|
Agilent Technologies Inc |
A |
Director |
2024-03-15 |
21,989 |
2024-03-15 |
14,450 |
Premium* |
|
|
Vir Biotechnology, Inc. |
VIR |
Director |
2024-02-26 |
112,989 |
2024-02-26 |
3,713,559 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
376 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 8 of 16
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2007-05-22 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,216 |
1,316,915 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2007-05-22 |
4 |
GA |
$0.00 |
$0 |
I/I |
4,216 |
8,963 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2007-05-24 |
4 |
AS |
$11.08 |
$28,250 |
D/D |
(2,500) |
1,314,415 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2007-05-30 |
4 |
AS |
$11.22 |
$28,260 |
D/D |
(2,500) |
1,311,915 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2007-06-08 |
4 |
AS |
$10.62 |
$26,915 |
D/D |
(2,500) |
1,309,415 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2007-06-11 |
4 |
AS |
$10.83 |
$27,373 |
D/D |
(2,500) |
1,306,915 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2007-06-20 |
4 |
AS |
$11.53 |
$29,168 |
D/D |
(2,500) |
1,304,415 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2007-06-29 |
4 |
AS |
$11.99 |
$30,546 |
D/D |
(2,500) |
1,301,915 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2007-07-06 |
4 |
AS |
$11.68 |
$29,686 |
D/D |
(2,500) |
1,299,415 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2007-07-12 |
4 |
AS |
$11.55 |
$29,069 |
D/D |
(2,500) |
1,296,915 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2007-07-20 |
4 |
AS |
$11.27 |
$28,512 |
D/D |
(2,500) |
1,294,415 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2007-07-26 |
4 |
AS |
$9.97 |
$25,483 |
D/D |
(2,500) |
1,291,915 |
0 |
- |
|
| ANDS |
Anadys Pharmaceuticals In... |
Director |
– • – |
2007-08-31 |
4 |
B |
$2.14 |
$48,227 |
D/D |
22,188 |
23,188 |
2.39 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2007-11-09 |
4 |
AS |
$11.08 |
$28,250 |
D/D |
(2,500) |
1,289,415 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2007-11-12 |
4 |
AS |
$9.08 |
$22,955 |
D/D |
(2,500) |
1,286,915 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2007-11-21 |
4 |
AS |
$8.01 |
$20,377 |
D/D |
(2,500) |
1,284,415 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2007-11-29 |
4 |
AS |
$8.63 |
$22,125 |
D/D |
(2,500) |
1,281,915 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2007-12-05 |
4 |
AS |
$8.36 |
$22,004 |
D/D |
(2,500) |
1,279,415 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2007-12-10 |
4 |
AS |
$8.52 |
$21,606 |
D/D |
(2,500) |
1,276,915 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2007-12-19 |
4 |
AS |
$8.96 |
$22,711 |
D/D |
(2,500) |
1,274,415 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2007-12-24 |
4 |
AS |
$9.23 |
$23,088 |
D/D |
(2,500) |
1,271,915 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2007-12-31 |
4 |
AS |
$8.57 |
$21,692 |
D/D |
(2,500) |
1,269,415 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2008-01-07 |
4 |
AS |
$8.29 |
$21,006 |
D/D |
(2,500) |
1,266,915 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2008-01-18 |
4 |
AS |
$7.48 |
$19,121 |
D/D |
(2,500) |
1,264,415 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2008-01-23 |
4 |
AS |
$6.83 |
$17,701 |
D/D |
(2,500) |
1,261,915 |
0 |
- |
|
376 Records found
|
|
Page 8 of 16 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
